New Owner
Valeant Pharmaceuticals International - Bausch & Lomb
Valeant Pharmaceuticals International acquires Bausch & Lomb
Announced: May 28, 2013
Type: Acquisition
Terms: Cash
Status: Complete
Amount: $ 8,700,000,000